Virtune AB (Publ)
5.3.2026 15:16:57 CET | Globenewswire | Press release
Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for February 2026 of its Virtune Crypto Top 10 Index ETP - the first crypto index ETP in the Nordics
Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for February 2026 of its Virtune Crypto Top 10 Index ETP - the first crypto index ETP in the Nordics
Stockholm, 5th of March 2026 - Virtune today announces the completion of the monthly rebalancing for the Virtune Crypto Top 10 Index ETP, listed on Nasdaq Stockholm for both the SEK-denominated (ISIN code SE0020052207, ticker name VIR10SEK) and the EUR-denominated (ISIN code SE0020052215, ticker name VIR10EUR) ETP.
In addition to the Virtune Crypto Top 10 Index ETP, Virtune's product portfolio includes:
Virtune Bitcoin ETP
Virtune Stellar ETP
Virtune Staked Ethereum ETP
Virtune Staked Solana ETP
Virtune Staked Polkadot ETP
Virtune XRP ETP
Virtune Avalanche ETP
Virtune Litecoin ETP
Virtune Chainlink ETP
Virtune Arbitrum ETP
Virtune Staked Polygon ETP
Virtune Staked Cardano ETP
Virtune Crypto Altcoin Index ETP
Virtune Bitcoin Prime ETP
Virtune Coinbase 50 Index ETP
Virtune Staked Near ETP
Virtune Sui ETP
Virtune Stablecoin ETP
Virtune Bittensor ETP
Virtune BNB ETP
Index allocation as of 26th of February:
Bitcoin: 41.74%
Ethereum: 28.47%
BNB: 9.86%
XRP: 10.02%
Solana: 5.69%
Cardano: 1.22%
Bitcoin Cash: 1.14%
Chainlink: 0.75%
Stellar: 0.61%
Litecoin: 0.50%
Index allocation as of 27th of February (after rebalancing):
Bitcoin: 40.00%
Ethereum: 28.85%
BNB: 10.15%
XRP: 10.83%
Solana: 5.68%
Cardano: 1.23%
Bitcoin Cash: 1.35%
Chainlink: 0.75%
Stellar: 0.66%
Litecoin: 0.50%
As part of this month’s rebalancing, no new assets are added to the index.
The performance of the Virtune Crypto Top 10 Index ETP SEK for February was -17.40%.
The rebalancing is carried out according to the index that the ETP tracks, the Virtune Crypto Top 10 Index. The purpose of the monthly rebalancing is to ensure that the ETP always reflects the current market conditions and to effectively absorb volatility in the crypto market.
Virtune's crypto index ETP is the first of its kind in the Nordic region. The ETP includes up to 10 leading crypto assets and are based on their total market capitalization, with a maximum weight of 40% per crypto asset to promote diversification. This allows investors to benefit from broad exposure to the crypto market without being heavily concentrated in any single crypto asset.
If you, as an (institutional) investor, are interested in meeting with Virtune to discuss the opportunities our ETPs offer for your asset management services or to learn more about Virtune and our ETPs, please do not hesitate to contact us at hello@virtune.com. You can also read more about Virtune and our ETPs at www.virtune.com and register your email address on our website to subscribe to our newsletters, which cover updates on Virtune's upcoming ETP launches and other news related to digital assets.
Press contact
Christopher Kock, CEO Virtune AB (Publ)
Christopher@virtune.com
+46 70 073 45 64
Virtune with its headquarters in Stockholm is a regulated Swedish digital asset manager and issuer of crypto exchange traded products on regulated European exchanges. With regulatory compliance, strategic collaborations with industry leaders and our proficient team, we empower investors on a global level to access innovative and sophisticated investment products that are aligned with the evolving landscape of the global crypto market.
Cryptocurrency investments are associated with high risk. Virtune does not provide investment advice. Investments are made at your own risk. Securities may increase or decrease in value, and there is no guarantee that you will recover your invested capital. Please read the prospectus, KID, terms at www.virtune.com.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Zealand Pharma5.3.2026 19:45:00 CET | Press release
Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and obesity
F. Hoffmann-La Roche Ltd5.3.2026 19:45:00 CET | Press release
Roche announces positive Phase II results for petrelintide, an amylin analog developed for people living with overweight and obesity
Esaote5.3.2026 19:30:25 CET | Press release
Esaote launches the new MyLabTM E85 GTS ultrasound system in Vienna
Facephi5.3.2026 19:27:32 CET | Press release
Facephi and Huenei Forge Strategic Alliance to Strengthen Digital Identity Solutions in Latin America and the United States
Sparekassen Sjælland-Fyn A/S5.3.2026 18:39:19 CET | Pressemeddelelse
Resultat af ordinær generalforsamling i SJF Bank (Sparekassen Sjælland-Fyn A/S)
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom